Bahrain: Approves emergency use of AstraZeneca vaccine

  • Date: 25-Jan-2021
  • Source: Gulf Insider
  • Sector:Healthcare
  • Country:Bahrain
  • Who else needs to know?

Bahrain: Approves emergency use of AstraZeneca vaccine

The National Health Regulatory Authority (NHRA) approved the emergency use of AstraZeneca vaccine against the COVID-19 yesterday. It is the third emergency vaccine approved in the Kingdom of Bahrain after Sinopharm and Pfizer/BioNTech.The study published by AstraZeneca showed that the vaccine is safe and has overall efficacy of 70.42% after the second dose.AstraZeneca is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, England.The vaccine is produced in cooperation with the University of Oxford and manufactured at the Cerum Institute of India.Comments Read Next1 hour agoUpdate: Random testing in Bahrain22 hours agoOman: 558 new coronavirus cases and 4 deaths22 hours agoDubai: First doses of Pfizer vaccine to be rescheduledDecember 25, 2020Bahrain suspends vaccination walk-in-service at health centersDecember 24, 2020COVID-19 vaccination in Bahrain: Online registration is mandatory!December 23, 2020Bahrain: COVID-19 vaccine available in all health centers from FridayDecember 22, 2020Saudi Arabia: COVID-19 vaccination centers to open soonDecember 17, 2020Remarkable turnout for COVID-19 vaccine in BahrainDecember 13, 2020Bahrain launches online registration for COVID-19 vaccinationDecember 13, 2020Bahrain approves Sinopharm COVID-19 vaccine